Advances in neurotoxicology, Journal Year: 2024, Volume and Issue: unknown
Published: Jan. 1, 2024
Language: Английский
Advances in neurotoxicology, Journal Year: 2024, Volume and Issue: unknown
Published: Jan. 1, 2024
Language: Английский
Elsevier eBooks, Journal Year: 2025, Volume and Issue: unknown
Published: Jan. 1, 2025
Language: Английский
Citations
0Toxicology, Journal Year: 2024, Volume and Issue: 510, P. 154000 - 154000
Published: Nov. 17, 2024
Language: Английский
Citations
2Advances in neurotoxicology, Journal Year: 2024, Volume and Issue: unknown, P. 83 - 106
Published: Jan. 1, 2024
Language: Английский
Citations
1Cells, Journal Year: 2024, Volume and Issue: 13(24), P. 2057 - 2057
Published: Dec. 12, 2024
Cell-based test methods with a phenotypic readout are frequently used for toxicity screening. However, guidance on how to validate the hits and integrate this information other data purposes of risk assessment is missing. We present here such procedure exemplify it case study neural crest cell (NCC)-based developmental picoxystrobin. A library potential environmental toxicants was screened in UKN2 assay, which simultaneously measures migration cytotoxicity NCC. Several strobilurin fungicides, known as inhibitors mitochondrial respiratory chain complex III, emerged specific hits. From these, picoxystrobin chosen roadmap leading from cell-based testing towards toxicological predictions. Following stringent confirmatory testing, an adverse outcome pathway developed provide testable hypothesis. Mechanistic studies showed that oxygen consumption rate inhibited at sub-µM concentrations after 24 h pre-exposure. Migration 100 nM range, under assay conditions forcing cells rely mitochondria. Biokinetic modeling predict intracellular concentrations. Assuming oral intake picoxystrobin, consistent acceptable daily level, physiologically based kinetic suggested brain 0.1–1 µM may be reached. Using broad array hazard toxicokinetics data, we calculated margin exposure ≥ 80 between lowest vitro point departure highest predicted tissue concentration. Thus, our exemplifies hit follow-up strategy contributes paving way next-generation assessment.
Language: Английский
Citations
1Toxicology, Journal Year: 2024, Volume and Issue: unknown, P. 153950 - 153950
Published: Sept. 1, 2024
Acrylamide (ACR) is a known neurotoxicant that can pass the placenta and has been detected in breast milk. Some vivo vitro studies indicate ACR exposure might lead to developmental neurotoxicity (DNT). Here, we have developed physiologically-based toxicokinetic model for pregnant human population using PK-Sim. We performed an extrapolation (IVIVE) of data collected from neuroblastoma SH-SY5Y cells exposed during differentiation ACR. The PBTK was successfully evaluated predicted fetal plasma concentrations low nM range after exposing estimated average daily intake women. IVIVE showed (fM-nM) induced attenuated neuronal cell model, were relevant oral intake. However, doses µM range, found be unrealistic by through food case due environmental pollution or occupational exposure, these may reached plasma. findings this study raise concern regarding pregnancy as well relevance testing are several orders magnitude higher than concentrations.
Language: Английский
Citations
0Elsevier eBooks, Journal Year: 2024, Volume and Issue: unknown
Published: Jan. 1, 2024
Language: Английский
Citations
0Advances in neurotoxicology, Journal Year: 2024, Volume and Issue: unknown
Published: Jan. 1, 2024
Language: Английский
Citations
0